Leo Brokerage’s Bristol-Myers Squibb BMY Stock Holding History

Leo Brokerage’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.57M	Buy	40,230 +15,866	+65%	+$1.06M	0.29%	52
2023 Q1	$1.69M	Buy	+24,364	New	+$1.72M	0.25%	79
2022 Q2	$710K	Sell	9,220 -3,120	-25%	-$238K	0.19%	73
2022 Q1	$902K	Buy	+12,340	New	+$829K	0.14%	102
2021 Q3	$359K	Buy	6,059 +848	+16%	+$55.8K	0.07%	133
2021 Q2	$348K	Sell	5,211 -700	-12%	-$45.6K	0.07%	138
2021 Q1	$373K	Sell	5,911 -314	-5%	-$19.5K	0.11%	131
2020 Q4	$386K	Buy	6,225 +802	+15%	+$49.3K	0.12%	109
2020 Q3	$319K	Buy	+5,423	New	+$326K	0.13%	92

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Leo Brokerage's BMY Position: Q2 2023 in Review

Leo Brokerage increased its Bristol-Myers Squibb (BMY) stake by 65% in Q2 2023, buying an estimated $1.06M and bringing the position to 40,230 shares worth $2.57M. The position accounts for 0.29% of the portfolio, ranked #52.

Leo Brokerage first reported a position in BMY in Q3 2020 and has held it in 9 quarters since. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Leo Brokerage held 40,230 shares of Bristol-Myers Squibb worth $2.57M as of Q2 2023.
Leo Brokerage bought 15,866 Bristol-Myers Squibb shares in Q2 2023, an estimated $1.06M.
Bristol-Myers Squibb made up 0.29% of Leo Brokerage's portfolio in Q2 2023, its #52 holding.
Leo Brokerage first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 9 quarters since.
2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.